High DNA damage levels to predict hematologic toxicity in testicular germ cell tumor (TGCT) patients treated with first-line chemotherapy.

被引：0
|
作者：
Mego, Michal
Hapakova, Nikola
Sestakova, Zuzana
Holickova, Andrea
Miskovska, Vera
Chovanec, Michal
Rejlekova, Katarina
Svetlovska, Daniela
Kalavska, Katarina
Obertova, Jana
Palacka, Patrik
De Angelis, Valentina
Sycova, Zuzana
Mardiak, Jozef
Chovanec, Miroslav
机构：
[1] Comenius Univ, Natl Canc Inst, Fac Med, Dept Oncol 2, Bratislava, Slovakia
[2] Natl Canc Inst, Bratislava, Slovakia
[3] Slovak Acad Sci, Bratislava, Slovakia
[4] Comenius Univ, Fac Med, Dept Oncol 1, Bratislava, Slovakia
[5] St Elisabeth Canc Inst, Bratislava, Slovakia
[6] Comenius Univ, Bratislava, Slovakia
[7] Natl Canc Inst, Bratislava, Slovakia
[8] Comenius Univ, Translat Res Unit, Natl Canc Inst, Bratislava, Slovakia
[9] Comenius Univ, Fac Med, Bratislava, Slovakia
[10] Natl Canc Inst, Dept Oncol 2, Bratislava, Slovakia
[11] Oncology, Bratislava, Slovakia
[12] Comenius Univ, Natl Canc Inst, Dept Clin Oncol, Bratislava, Slovakia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e16055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16055
引用
收藏
页数：2
相关论文
共 50 条
  • [1] High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy
    Hapakova, Nikola
    Sestakova, Zuzana
    Holickova, Andrea
    Hurbanova, Lenka
    Miskovska, Vera
    Chovanec, Michal
    Rejlekova, Katarina
    Svetlovska, Daniela
    Kalavska, Katarina
    Obertova, Jana
    Palacka, Patrik
    Sycova-Mila, Zuzana
    Mardiak, Jozef
    Chovanec, Miroslav
    Mego, Michal
    CLINICAL GENITOURINARY CANCER, 2019, 17 (05) : E1020 - E1025
  • [2] The role of paclitaxel in the first-line treatment of patients with 'poor prognosis' germ cell tumor (GCT) undergoing sequential high dose chemotherapy.
    Hartman, JT
    Rick, O
    Thomas, M
    Schleicher, J
    Metzner, B
    Flasshove, M
    Kollmannsberger, C
    Schmoll, HJ
    Kanz, L
    Bokemeyer, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 415S - 415S
  • [3] Conditional Survival of Patients With Metastatic Testicular Germ Cell Tumors Treated With First-Line Curative Therapy
    Ko, Jenny J.
    Bernard, Brandon
    Tran, Ben
    Li, Haocheng
    Asif, Tehmina
    Stukalin, Igor
    Lee, Margaret
    Day, Daphne
    Alimohamed, Nimira
    Sweeney, Christopher J.
    Bedard, Philippe L.
    Heng, Daniel Y. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07) : 714 - +
  • [4] Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy
    Caso, Raul
    Jones, Gregory D.
    Tan, Kay See
    Bosl, George J.
    Funt, Samuel A.
    Sheinfeld, Joel
    Reuter, Victor E.
    Amar, David
    Fischer, Gregory
    Molena, Daniela
    Rocco, Gaetano
    Bains, Manjit S.
    Feldman, Darren R.
    Jones, David R.
    ANNALS OF THORACIC SURGERY, 2021, 111 (04): : 1141 - 1149
  • [5] Re: Conditional Survival of Patients with Metastatic Testicular Germ Cell Tumors Treated with First-Line Curative Therapy
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2017, 197 (01): : 158 - 158
  • [6] Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor
    King, Jennifer M.
    Althouse, Sandra
    Cary, Clint
    Masterson, Timothy
    Foster, Richard S.
    Ashkar, Ryan
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF UROLOGY, 2022, 208 (03): : 641 - 649
  • [7] DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
    Ronchetti, Livia
    Melucci, Elisa
    De Nicola, Francesca
    Goeman, Frauke
    Casini, Beatrice
    Sperati, Francesca
    Pallocca, Matteo
    Terrenato, Irene
    Pizzuti, Laura
    Vici, Patrizia
    Sergi, Domenico
    Di Lauro, Luigi
    Amoreo, Carla Azzurra
    Gallo, Enzo
    Diodoro, Maria Grazia
    Pescarmona, Edoardo
    Vitale, Ilio
    Barba, Maddalena
    Buglioni, Simonetta
    Mottolese, Marcella
    Fanciulli, Maurizio
    De Maria, Ruggero
    Maugeri-Sacca, Marcello
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (11) : 2587 - 2595
  • [8] First-line high-dose chemotherapy for 'poor risk' metastatic non-seminomatous testicular germ cell tumors
    Bokemeyer, C
    Harstrick, A
    Beyer, J
    Metzner, B
    Rüther, U
    Hartmann, JT
    Holstein, K
    Derigs, HG
    de Wit, R
    Casper, J
    Schöffski, P
    Kührer, I
    Illiger, HJ
    Kempf, B
    Reichle, A
    Föller, A
    Hossfeld, DK
    Fischer, JT
    Berdel, W
    Gerhartz, H
    Kirchner, H
    Pflüger, K
    Ostermann, H
    Kanz, L
    Schmoll, HJ
    ONKOLOGIE, 1998, 21 : 23 - 25
  • [9] Treatment patterns, toxicity, and outcomes of elderly patients with advanced pancreatic cancer receiving first-line chemotherapy.
    Kudlovich, Robert
    Zhang, Hanbo
    Kim, Christina
    Dawe, David
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [10] High expression levels of NOXA are important for p53-mediated hypersensitivity in testicular germ cell tumor (TGCT) cells
    Gutekunst, Matthias
    Oren, Moshe
    Weilbacher, Andrea
    Dengler, Michael A.
    Aulitzky, Walter E.
    van der Kuip, Heiko
    CANCER RESEARCH, 2011, 71
12345